https://doctransparency.com/doctor/tx/dallas/robyn-olney-1467642611
Medicare Enrolled

Dr. Robyn Olney, M.D.

Pathology - Anatomic · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3417 GASTON AVE STE 630, Dallas, TX 75246
4698009000
In practice since 2007 (18 years)
NPI: 1467642611 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Olney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Olney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Olney

Dr. Robyn Olney is a pathology - anatomic in Dallas, TX, with 18 years in practice. Based on federal Medicare data, Dr. Olney performed 683,837 Medicare services across 515,674 unique beneficiaries.

Between the years covered by Open Payments, Dr. Olney received a total of $30 from 1 pharmaceutical and/or device company across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pathology - anatomic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Olney is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 0% volume in TX$ $30 industry payments

Medicare Practice Summary

Medicare Utilization ↗
683,837
Medicare services
Top 0% in TX for pathology - anatomic
515,674
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~37,991 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Comprehensive metabolic blood panel103,700$10$80
Complete blood count (CBC) with differential86,873$8$47
Lipid panel (cholesterol and triglycerides)78,588$13$83
Thyroid stimulating hormone (TSH) test64,446$16$101
Hemoglobin A1c test (diabetes monitoring)45,259$9$58
Creatinine test (kidney function)33,804$5$56
Urine microalbumin test (kidney screening)33,048$6$51
Vitamin D level test25,812$29$178
Urinalysis with microscopic exam17,727$3$22
Free thyroxine (T4) test17,492$9$69
Urine culture, bacterial colony count13,685$8$48
Basic metabolic blood panel12,958$8$65
Vitamin B-12 level test9,837$15$90
Prostate cancer screening; prostate specific antigen test (psa)8,744$19$56
Antibiotic sensitivity test7,592$8$52
Iron level test7,237$6$39
Ferritin level test (iron stores)6,998$13$82
Iron binding capacity test6,984$9$52
PSA test (prostate cancer screening)6,728$18$110
Bacterial culture, aerobic6,269$8$48
Sed rate test (inflammation marker)4,991$3$22
Automated urinalysis4,958$2$20
C-reactive protein test (inflammation marker)4,776$5$35
Magnesium level test4,478$7$40
Thyroxine (thyroid chemical), total4,308$7$52
Thyroid hormone evaluation4,193$6$51
Blood draw (venipuncture)4,120$8$17
Natriuretic peptide (heart and blood vessel protein) level3,737$38$236
Folic acid level test3,635$14$88
Uric acid level test3,622$4$27
Parathyroid hormone level test3,430$40$248
Hepatitis c antibody measurement3,393$14$128
Thyroid hormone, t3 measurement, free3,194$17$102
Liver function blood test panel2,231$8$69
Measurement of antibody for assessment of autoimmune disorder, any method2,201$17$108
Testosterone (hormone) level, total1,839$25$155
Complete blood count (CBC), automated1,509$6$39
Phosphate level test1,431$5$28
Creatine kinase (cardiac enzyme) level, total1,386$6$39
Lipase (fat enzyme) level1,266$7$41
Analysis of substance using immunoassay technique, multiple step method1,173$11$69
Rheumatoid factor level1,156$6$35
Sex hormone binding globulin (protein) level996$21$130
Kidney function blood test panel948$8$75
Thyroid hormone, t3 measurement, total903$14$85
Yeast/candida DNA test792$34$211
Detection test for candida species (yeast), direct probe technique779$20$120
Alpha-fetoprotein (afp) level, serum750$16$101
Screening test for autoimmune disorder687$12$73
Measurement of complement (immune system proteins), antigen,668$12$109
Total protein level, urine644$4$30
Amylase (enzyme) level643$6$39
Immunoglobulin level test632$9$56
Measurement of antibody for rheumatoid arthritis assessment592$13$78
Calcium level, total588$5$36
Measurement of hepatitis a antibody572$12$74
Stool culture, additional pathogens565$9$57
Microsomal antibodies (autoantibody) measurement544$14$97
Detection test by nucleic acid for human papillomavirus (hpv), high-risk types481$34$211
Pap test, automated thin layer preparation; automated system and manual rescreening467$26$160
Measurement of substance using immunoassay technique444$17$104
Cortisol (hormone) measurement, total423$16$206
Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique420$34$211
Measurement of dna antibody, native or double stranded397$13$82
Psa (prostate specific antigen) measurement, free386$18$110
Blood creatinine level381$5$31
Homocysteine (amino acid) level374$17$108
Measurement of total estradiol (hormone)367$27$168
Glutamyltransferase (liver enzyme) level332$7$43
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r313$74$172
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within311$24$50
Thyroglobulin (thyroid protein) antibody measurement297$16$95
Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies294$23$144
Prolactin (milk producing hormone) level282$19$116
Drug screening test278$15$15
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen278$50$172
Liver enzyme (sgpt), level258$5$32
Red blood count, automated test237$4$25
Gonadotropin, follicle stimulating (reproductive hormone) level228$18$111
Identification of organisms by immunologic analysis, other than immunofluorescence method228$5$35
Insulin measurement, total225$11$71
Blood potassium level215$5$29
Liver enzyme (sgot), level211$5$31
Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody196$41$86
Tissue pathology examination, moderate complexity196$28$254
Alpha-1-antitrypsin (protein) blood test, total194$13$81
Stool analysis for blood, by peroxidase activity192$4$25
Ldl cholesterol level185$10$63
Special stained specimen slides to examine tissue including interpretation and report184$9$82
Lactate dehydrogenase (enzyme) level168$6$39
Tissue staining for diagnosis, additional167$21$178
Gonadotropin, luteinizing (reproductive hormone) level165$18$111
C-peptide (protein) level145$20$125
Progesterone (reproductive hormone) level130$20$125
Antibody testing for syphilis127$31$91
Measurement c-reactive protein for detection of infection or inflammation, high sensitivity107$13$78
Tissue staining for diagnosis, initial104$27$266
Red blood cell concentration measurement99$2$15
Troponin (protein) analysis, quantitative96$12$75
Blood count, hemoglobin92$2$15
Albumin (protein) level80$5$30
Acute hepatitis panel68$47$286
Blood glucose (sugar) level66$4$25
Preparation of tissue for examination by removing any calcium present64$9$80
Flow cytometry technique for dna or cell analysis, 16 or more markers62$61$664
Bone marrow, smear interpretation56$36$511
Bilirubin level, direct54$5$30
Urine calcium level49$6$36
Blood sodium level46$5$29
Analysis for antibody to herpes simplex virus, type 243$19$116
Blood smear interpretation by physician with written report37$18$154
Analysis for antibody to herpes simplex virus, type 136$13$79
Measurement of rna of bacteria in vaginal fluid specimen30$140$856
Detection test by nucleic acid for herpes simplex virus, amplified probe technique26$34$211
Prothrombin time test (blood clotting)24$3$26
Bilirubin level, total22$5$35
Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets22$140$856
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous22$18$52
Transferrin (iron binding protein) level21$12$77
Hepatitis b core antibody (igm) measurement20$12$71
Hepatitis b surface antibody measurement19$10$74
Microscopic genetic analysis of tumor, manual19$32$362
Screening test for mononucleosis (mono)18$5$31
Detection test by immunoassay technique for hepatitis b surface antigen18$9$62
Pathology examination of tissue using a microscope, moderately high complexity18$63$535
Hepatitis b core antibody measurement17$11$72
Gonadotropin (reproductive hormone) analysis16$7$68
Measurement of hepatitis a antibody (igm)15$10$68
Pathology cytologic examination of specimen during surgery, initial site14$48$363
Blood bank physician services for cross match and/or evaluation and written report13$39$365
Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique13$32$211
Total protein level, blood12$3$29
Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique12$32$211
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$30
Total received (2024-2024)
Bottom 22% in TX for pathology - anatomic
1
Company
2
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$30

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$30
Top 3 companies account for 100.0% of total payments
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pathology - anatomic in Dallas?
Compare pathology - anatomics in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse pathology - anatomics nearby

Geographic Context

Pathology - Anatomics within 10 mi
230
Per 100K population
8.8
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Olney is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Olney experienced with comprehensive metabolic blood panel?
Based on Medicare claims data, Dr. Olney performed 103,700 comprehensive metabolic blood panel services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Olney receive payments from pharmaceutical companies?
Yes. Dr. Olney received a total of $30 from 1 company across 2 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Olney's costs compare to other pathology - anatomics in Dallas?
Dr. Olney's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Olney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →